1-3 of 3
Harald Wajant, PhD
Close
Sort by
Journal Articles

TNFR2 Is Expressed Preferentially By Late Differentiated CD8 T-Cells and Can be Triggered By TNFR2-Specific Ligand to Induce Cell Death of Recently Activated Antigen-Specific T Cells: A Possible Role of TNFR2 in T-Cell Deflation

Mohammad Raeiszadeh, MPhil, Matthew Verney, MSc, Charles Craddock, MDPhD, Harald Wajant, PhD, Paul Moss, MDPhD, Frederick Chen, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4352.
https://doi.org/10.1182/blood.V124.21.4352.4352
Published: 2014
Journal Articles

A Selective TNFR2 Agonist Expands Host T reg Cells in Vivo to Protect from Acute Graft-Versus-Host Disease

Andreas Beilhack, MD, Martin Chopra, PhD, Marlene Biehl, Martin Vaeth, PhD, Andreas Brandl, PhD, Jorge Amich, PhD, Janina Findeis, Ana-Laura Jordán Garrote, PhD, Christian Brede, PhD, Carina A Bäuerlein, PhD, Stefanie Schwinn, Hermann Einsele, MD, Friederike Berberich-Siebelt, PhD, Harald Wajant, PhD
Journal: Blood
Blood (2014) 124 (21): 1099.
https://doi.org/10.1182/blood.V124.21.1099.1099
Published: 2014
Journal Articles

CD40-Licensing Of Human Dendritic Cells Further Matures Tnfa-Treated Dcs But Does Not Mediate Resistance Against Inhibition Of T-Cell Proliferation By T REG

Matthias Eyrich, PhD, MD, Johannes Rachor, Marissa Blume, Isabelle Becker, Anne Stumpf, Harald Wajant, PhD, Matthias Wolfl, MD, Paul G. Schlegel, MD, Manfred Lutz, PhD
Journal: Blood
Blood (2013) 122 (21): 4726.
https://doi.org/10.1182/blood.V122.21.4726.4726
Published: 2013